医学
危险系数
无症状的
四分位间距
蒽环类
内科学
置信区间
临床终点
心力衰竭
弗雷明翰风险评分
临床试验
癌症
乳腺癌
疾病
作者
Borja Rivero Santana,Jesús Saldaña García,Juan Caro‐Codón,Pilar Zamora,Pedro Moliner,A. Martínez Monzonís,Eduardo Zatarain‐Nicolás,Carlos Álvarez-Ortega,Pilar Gómez‐Prieto,Sònia Pernas,Isabel Rodrı́guez,Antonio Buño Soto,Rosalía Cádenas,Patricia Palacios Ozores,Sara Ramírez,María Merino Salvador,Silvia Valbuena-López,Lucía Fernández Gassó,V Juarez,Andrea Severo Sánchez
标识
DOI:10.1093/eurheartj/ehae496
摘要
The HFA-ICOS score effectively categorizes patients by cardiovascular toxicity risk and demonstrates strong predictive ability for high-risk anthracycline-related cardiovascular toxicity and all-cause mortality.
科研通智能强力驱动
Strongly Powered by AbleSci AI